Anke Geick
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
Papers in
-
- RNA Interference and Gene Delivery 4
- Advanced biosensing and bioanalysis techniques 4
- Cell death mechanisms and regulation 2
- Angiogenesis and VEGF in Cancer 1
- Oncology 3
- Drug Transport and Resistance Mechanisms 2
- Co-authors
- Oliver Burk (3 shared papers)Michel Eichelbaum (3 shared papers)Heike Tegude (1 shared paper)Jonathan Nedrelow (1 shared paper)Jack A. Elias (1 shared paper)Antonin R. de Fougerolles (1 shared paper)Chun Geun Lee (1 shared paper)Zhou Zhu (1 shared paper)
- Journals
- Molecular Therapy (1 paper)Nature Medicine (1 paper)Clinical Pharmacology & Therapeutics (1 paper)Anti-Cancer Drugs (1 paper)Biological Chemistry (1 paper)
- Partner nations
- GermanyAustriaSwitzerland
In The Last Decade
Anke Geick
11 papers receiving 1.4k citations
Anke Geick's Hit Papers
Peers
Comparison fields: 5 of 87
- Pharmacology 459
- Oncology 637
- Pediatrics, Perinatology and Child Health 241
- Endocrinology, Diabetes and Metabolism 119
- Immunology 117
Countries citing papers authored by Anke Geick
This map shows the geographic impact of Anke Geick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Geick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Geick more than expected).
Fields of papers citing papers by Anke Geick
This network shows the impact of papers produced by Anke Geick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Geick. The network helps show where Anke Geick may publish in the future.
Co-authors
The 25 scholars most cited alongside Anke Geick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by Rifampin Hit paper breakdown → | 2001 | 734 |
| 2 | 2006 | 279 | |
| 3 | 2005 | 128 | |
| 4 | 1996 | 54 | |
| 5 | 2003 | 51 | |
| 6 | 2001 | 45 | |
| 7 | 2002 | 41 | |
| 8 | 2011 | 38 | |
| 9 | 2007 | 23 | |
| 10 | 2001 | 12 | |
| 11 | 2003 | 6 |
About Anke Geick
Anke Geick is a scholar working on Molecular Biology, Oncology, Pharmacology, Genetics and Cancer Research, having authored 11 papers that have together received 1.4k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (4 papers), Advanced biosensing and bioanalysis techniques (4 papers), Pharmacogenetics and Drug Metabolism (2 papers), Cell death mechanisms and regulation (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Angiogenesis and VEGF in Cancer (1 paper), Hormonal Regulation and Hypertension (1 paper) and Estrogen and related hormone effects (1 paper). The work is most often cited by research in Pharmacology (459 citations), Oncology (637 citations), Pediatrics, Perinatology and Child Health (241 citations), Endocrinology, Diabetes and Metabolism (119 citations) and Immunology (117 citations). Anke Geick has collaborated with scholars based in Germany, Austria and Switzerland. Frequent co-authors include Oliver Burk, Michel Eichelbaum, Heike Tegude, Jonathan Nedrelow, Jack A. Elias, Antonin R. de Fougerolles, Chun Geun Lee, Zhou Zhu, Patty J. Lee and Rayman Choo-Wing. Their work appears in journals such as Molecular Therapy, Nature Medicine, Clinical Pharmacology & Therapeutics, Anti-Cancer Drugs and Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.